There won’t be any dispute on blood testing this time around. Floyd Mayweather jr. and Shane Mosley have agreed to use Olympic-style drug testing for their fight on May 1 at the MGM Grand in Las Vegas.
Much was made of the issue after Mayweather demanded that Manny Pacquiao agree to random blood testing. Pacquiao refused, which halted plans for a mega-fight between two. Mosley, who has been lobbying for a chance at Mayweather or Pacquiao for several years, said he was more than willing to take random blood tests. “If he wants to test, no problem, I’ll take one. I would’ve agreed to it before and after 2003,” Mosley said at a press conference earlier this month. “I live my life clean.”
Representatives of the fighters joined Travis Tygart of the U.S.
Anti-Doping Agency yesterday to discuss the program in a
Mayweather (40-0, 25 KOs) has made references to Mosley’s (46-5, 39 KOs) links to BALCO on several occasions. Mosley, according to leaked grand jury testimony, admitted to unknowingly taking steroids in 2003. “We know when he was on steroids, he was fast,” Mayweather said when asked at the press conference about Mosley’s speed.
Mayweather, who still believes Pacquiao is using performance enhancing drugs, said he hopes that someday all states require boxers to submit to random blood testing. Blood testing is not required by the Nevada State Athletic Commission, which only uses urine samples.
But Keith Kizer, the executive director of the Nevada’s athletic commission, told Newsday earlier this month they would welcome the results. “If they are taking blood tests, I would want to see copies of those tests, along with their MRIs and HIV tests,” Kizer said.
The USADA will oversee the tests, which can be administered before and or after the fights. Mayweather and Mosley met with officials from the anti-doping agency last weekend to provide whereabouts information and learn about the testing, which is similar to testing used in amateur
It’s not clear what the punishment would be if either fighter tested positive for a performance enhancing drug.
*Information from the AP was used in this report